Angiosarcoma of the scalp is a rare aggressive tumor that affects elderly patients. Chemoradiation is the treatment of choice for multicentric and extensive disease. The shape of the scalp represents a dosimetric challenge in terms of achieving a homogeneous concave dose distribution with coverage of the entire target volume and an acceptable organs-at-risk sparing. We report a case of an 81-year-old man with a multifocal angiosarcoma of the scalp treated with Helical TomoTherapy® (Accuray Inc., Sunnyvale, CA, USA) intensity modulated radiotherapy. This technique allows precise and daily verifiable coverage of the target keeping the dose to the organs at risk within the constraints.
Cuccia F., Figlia V., Palmeri A., Verderame F., Lo Casto A., Mannino M., et al. (2017). Helical tomotherapy® is a safe and feasible technique for total scalp irradiation. RARE TUMORS, 9(1), 7-8 [10.4081/rt.2017.6942].
Helical tomotherapy® is a safe and feasible technique for total scalp irradiation
Cuccia F.;Figlia V.;Palmeri A.;Lo Casto A.;
2017-03-28
Abstract
Angiosarcoma of the scalp is a rare aggressive tumor that affects elderly patients. Chemoradiation is the treatment of choice for multicentric and extensive disease. The shape of the scalp represents a dosimetric challenge in terms of achieving a homogeneous concave dose distribution with coverage of the entire target volume and an acceptable organs-at-risk sparing. We report a case of an 81-year-old man with a multifocal angiosarcoma of the scalp treated with Helical TomoTherapy® (Accuray Inc., Sunnyvale, CA, USA) intensity modulated radiotherapy. This technique allows precise and daily verifiable coverage of the target keeping the dose to the organs at risk within the constraints.| File | Dimensione | Formato | |
|---|---|---|---|
|
LoCastoAScalpAngiosarcomaRareTumors2017.pdf
accesso aperto
Descrizione: Articolo
Tipologia:
Versione Editoriale
Dimensione
81.38 kB
Formato
Adobe PDF
|
81.38 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


